Chewy, Inc. (CHWY) - Form 10-K Summary
Business Context and Reporting Period
This filing is the Annual Report on Form 10-K for Chewy, Inc., covering the fiscal year ended February 1, 2026 (Fiscal Year 2025). Chewy is the largest pet e-tailer in the United States, offering pet food, supplies, and health services through its website and mobile applications. The company operates a single reportable segment and serves customers in the U.S. and Canada. As of the reporting date, Chewy employed approximately 18,000 full-time and part-time employees.
Key Financial Metrics
| Metric | Fiscal 2025 | Fiscal 2024 | Change |
|---|---|---|---|
| Net Sales | $12,601.5 million | $11,861.3 million | +6.2% |
| Gross Profit | $3,753.9 million | $3,467.7 million | +8.3% |
| Gross Margin | 29.8% | 29.2% | +60 bps |
| Net Income (GAAP) | $222.8 million | $392.7 million | -43.3% |
| Net Margin (GAAP) | 1.8% | 3.3% | -150 bps |
| Adjusted EBITDA | $719.2 million | $570.5 million | +26.1% |
| Adjusted EBITDA Margin | 5.7% | 4.8% | +90 bps |
| Free Cash Flow | $562.4 million | $452.5 million | +24.3% |
| Operating Cash Flow | $691.6 million | $596.3 million | +16.0% |
| Active Customers | 21.3 million | 20.5 million | +4.0% |
| Autoship Sales % of Net Sales | 83.3% | 79.2% | +410 bps |
Liquidity and Debt: As of February 1, 2026, Chewy held $860.1 million in cash and cash equivalents and $18.7 million in marketable securities. The company maintains an $800 million senior secured asset-based revolving credit facility (ABL) with no outstanding borrowings as of the reporting date. Total lease obligations were $857.4 million.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 6.2% year-over-year, driven by an 11.8% increase in Autoship customer sales and a 2.2% increase in net sales per active customer. Growth was broad-based across consumables, pet health, and hardgoods.
- Profitability Decline (GAAP): GAAP net income decreased 43.3% to $222.8 million. This decline was primarily due to the absence of a $275.7 million release of valuation allowance on deferred tax assets that occurred in Fiscal 2024, which is a non-cash, non-recurring item.
- Operating Efficiency: Adjusted EBITDA grew 26.1% to $719.2 million, reflecting improved operational leverage and margin expansion despite higher fulfillment and marketing costs.
- Share Repurchases: The company repurchased $262.5 million of common stock during Fiscal 2025, including significant concurrent repurchases from affiliates of BC Partners. Approximately $249.9 million remains available under the current repurchase program.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted the resilience of the pet industry and the success of the Autoship subscription model, which now accounts for over 83% of net sales. The company continues to invest in fulfillment infrastructure, veterinary clinics (expanding to 18 locations), and private brands. A major strategic move was the acquisition of SmartPak Equine, LLC for $175 million, completed on February 2, 2026, to expand into the equine health and nutrition market.
Risks and Contingencies:
- Macroeconomic Conditions: Inflation, elevated interest rates, and economic uncertainty could impact consumer spending and increase operational costs.
- Competition: Intense competition from omnichannel retailers, mass merchandisers, and other e-commerce players.
- Supply Chain: Risks related to shipping disruptions, supplier concentration (top three vendors represent ~39% of sales), and inventory management.
- Regulatory: Compliance with evolving laws regarding pet health services, pharmacy operations, data privacy, and e-commerce taxation.
- Cybersecurity: Ongoing threats to data security and network infrastructure.
Key Facts for Investor Verification
- GAAP vs. Non-GAAP: Verify the significant divergence between GAAP net income (down 43%) and Adjusted EBITDA (up 26%) due to the one-time tax benefit in the prior year.
- Share Repurchase Activity: Confirm the extent of share buybacks from controlling shareholders (BC Partners affiliates) versus open market purchases and the remaining authorization ($249.9 million).
- SmartPak Acquisition: Review the purchase price allocation and integration plans for the $175 million SmartPak Equine acquisition completed immediately after the fiscal year-end.
- Autoship Dependency: Assess the sustainability of growth given that 83.3% of revenue is derived from the Autoship subscription program.
- Capital Allocation: Monitor the balance between capital expenditures ($129.2 million in FY2025) for fulfillment/clinic expansion and cash returned to shareholders via buybacks.